RB1CC1 and breast neoplasm: Immunohistochemical evaluation of RB1 and p53 in combination with RB1CC1 may be a useful biomarker in convenient, routine clinical assays and provide a prediction of the biological behavior of breast neoplasms and/or the tumors of other organs.